Virtual Reality in End Stage Kidney Disease
ConditionEnd Stage Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Pennsylvania
About this trial
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month
Disqualifiers
Acutely ill
Active nausea
Epilepsy
Trial design
Design model
Parallel
Treatments tested in this trial
Social Virtual Reality
BehavioralParticipants interact using virtual reality during dialysis.
Individual Virtual Reality
BehavioralParticipants use virtual reality alone during dialysis.
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: Social Virtual RealityExperimental treatment 1 intervention
Group B: Individual Virtual RealityActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
De Jong Gierveld Scale
Measures how bad or severe a person's loneliness is. Score range from 11-44; higher scores indicate more loneliness.
Time frame
Baseline and 4 WeeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov